Welcome to LookChem.com Sign In|Join Free
  • or
Home > Pharmaceutical > 7640 > 

7640-37-1

Products Categories

Basic Information
CAS No.: 7640-37-1
Name: Amidon
Article Data: 144
Molecular Structure:
Molecular Structure of 7640-37-1 (Amidon)
Formula: N/A
Molecular Weight: 137.141
  • Display:default sort

    New supplier

  • isoniazid

  • Casno:

    7640-37-1

    isoniazid

    Min.Order: 1 Gram

    FOB Price:  USD $ 0.0-0.0

    1.In No Less 10 years exporting experience. you can 100% received goods 2.Lower Price with higher quality 3,Free sample 4,We are sincerely responsible for the "product quality" and "After Service" Upbio is Specializ

    Shanghai Upbio Tech Co.,Ltd (Former Onchem (China)Co.,Ltd) is a comprehensive manufacturer and an international distribution of chemicals throughout the world, The predecessor of

  •  Shanghai Upbio Tech Co.,Ltd

     China (Mainland)  |  Contact Details

    Business Type:Lab/Research institutions

    Tel:+86-21-52196435

    Address:No.2 Floor,No.979 Yunhan Rd,Nicheng,Pudong New Area,Shanghai,China

       Inquiry Now

  • Total:1 Page 1 of 1 1
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7640-37-1

Chemistry


IUPAC Name: Pyridine-4-carbohydrazide
Molecular Formula: C6H7N3O
Molecular Weight: 137.13928 g/mol
Canonical SMILES: C1=CN=CC=C1C(=O)NN
InChI: InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)
Classification Code: Anti-Bacterial Agents; Anti-Infective Agents; Antibacterial [tuberculostatic]; Antilipemic Agents; Antimetabolites; Antitubercular agents; Drug / Therapeutic Agent; Fatty Acid Synthesis Inhibitors; Human Data; Mutation data; Reproductive Effect; Skin / Eye Irritant; Tumor data
Melting Point: 171.4 °C
Index of Refraction: 1.583
Molar Refractivity: 36.86 cm3
Molar Volume: 110.1 cm3
Surface Tension: 57.8 dyne/cm
Density of Isoniazid (CAS NO.7640-37-1): 1.244 g/cm3

Uses

 Isoniazid (CAS NO.7640-37-1) is the first-line antituberculosis medication in prevention and treatment. It is the most potent and selective of the tuberculostatic antibacterial agents.

Production

 Isoniazid may be prepared by the base hydrolysis of 4-cyanopyridine to give the amide, followed by displacement of ammonia by hydrazine:
                  

Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 intraperitoneal 325mg/kg (325mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Klinische Wochenscrift. Vol. 30, Pg. 959, 1952.
child TDLo oral 125mg/kg (125mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: COMA
Annals of Emergency Medicine. Vol. 17, Pg. 73, 1988.
child TDLo oral 195mg/kg (195mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: HEADACHE
Japanese Journal of Toxicology. Vol. 12, Pg. 225, 1999.
child TDLo oral 3600mg/kg/43W (3600mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

BEHAVIORAL: ATAXIA

BEHAVIORAL: TREMOR
Canadian Medical Association Journal. Vol. 148, Pg. 49, 1993.
dog LD50 oral 50mg/kg (50mg/kg)   American Review of Tuberculosis. Vol. 65, Pg. 392, 1952.
guinea pig LD50 intramuscular 255mg/kg (255mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. Vol. 9, Pg. 226, 1952.
guinea pig LD50 intraperitoneal 195mg/kg (195mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Klinische Wochenscrift. Vol. 30, Pg. 959, 1952.
guinea pig LD50 intravenous 220mg/kg (220mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" Archiv fuer Toxikologie. Vol. 22, Pg. 80, 1966.
guinea pig LD50 oral 255mg/kg (255mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. Vol. 9, Pg. 226, 1952.
guinea pig LD50 subcutaneous 195mg/kg (195mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. Vol. 9, Pg. 226, 1952.
human LDLo oral 100mg/kg (100mg/kg) PERIPHERAL NERVE AND SENSATION: STRUCTURAL CHANGE IN NERVE OR SHEATH American Review of Respiratory Disease. Vol. 105, Pg. 206, 1972.
infant TDLo oral 91mg/kg (91mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Pediatrics. Vol. 95, Pg. 700, 1995.
man LDLo oral 116mg/kg (116mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

CARDIAC: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: EMPHYSEMA
Journal of Analytical Toxicology. Vol. 16, Pg. 57, 1992.
man LDLo oral 523mg/kg/17W- (523mg/kg) LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE"

LIVER: "HEPATITIS, FIBROUS (CIRRHOSIS, POST-NECROTIC SCARRING)"
JAMA, Journal of the American Medical Association. Vol. 176, Pg. 877, 1961.
man TDLo oral 39mg/kg/9D-I (39mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Southern Medical Journal. Vol. 75, Pg. 81, 1982.
man TDLo oral 100mg/kg/3W-C (100mg/kg) BEHAVIORAL: ANOREXIA (HUMAN

SKIN AND APPENDAGES (SKIN): SWEATING: OTHER

KIDNEY, URETER, AND BLADDER: OTHER CHANGES
American Review of Respiratory Disease. Vol. 106, Pg. 849, 1972.
man TDLo oral 430mg/kg (430mg/kg) BEHAVIORAL: GENERAL ANESTHETIC

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Neurology. Vol. 20, Pg. 299, 1970.
mouse LD50 intramuscular 137mg/kg (137mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
American Review of Tuberculosis. Vol. 65, Pg. 376, 1952.
mouse LD50 intraperitoneal 100mg/kg (100mg/kg)   National Technical Information Service. Vol. AD277-689,
mouse LD50 intravenous 149mg/kg (149mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Pharmacology and Experimental Therapeutics. Vol. 122, Pg. 110, 1958.
mouse LD50 oral 133mg/kg (133mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
American Review of Tuberculosis. Vol. 65, Pg. 376, 1952.
mouse LD50 subcutaneous 125mg/kg (125mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Yakugaku Zasshi. Journal of Pharmacy. Vol. 81, Pg. 1225, 1961.
rabbit LD50 intracrebral > 12mg/kg (12mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. Vol. 9, Pg. 226, 1952.
rabbit LD50 intramuscular 155mg/kg (155mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. Vol. 9, Pg. 226, 1952.
rabbit LD50 intraperitoneal 147mg/kg (147mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. Vol. 9, Pg. 226, 1952.
rabbit LD50 intravenous 94mg/kg (94mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD American Review of Tuberculosis. Vol. 65, Pg. 376, 1952.
rabbit LD50 oral 250mg/kg (250mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 12, Pg. 22, 1962.
rabbit LD50 subcutaneous 135mg/kg (135mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. Vol. 9, Pg. 226, 1952.
rat LD50 intramuscular 400mg/kg (400mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Therapie. Vol. 8, Pg. 62, 1953.
rat LD50 intraperitoneal 335mg/kg (335mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Schweizerische Zeitschrift fuer Tuberkulose und Pneumonologie. Vol. 9, Pg. 226, 1952.
rat LD50 intravenous 365mg/kg (365mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 409, 1976.
rat LD50 oral 1250mg/kg (1250mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 409, 1976.
 
rat LD50 subcutaneous 329mg/kg (329mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 119, Pg. 444, 1957.
women TDLo oral 12mg/kg/2D-I (12mg/kg) BEHAVIORAL: TOXIC PSYCHOSIS

BEHAVIORAL: ATAXIA
Neurology. Vol. 34, Pg. 703, 1984.
women TDLo oral 90200ug/kg/7D (90.2mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: HEADACHE

CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE
Pediatrics. Vol. 97, Pg. 782, 1996.
women TDLo oral 99300ug/kg (99.3mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: NAUSEA OR VOMITING
Pediatrics. Vol. 95, Pg. 700, 1995.
women TDLo oral 11250mg/kg (11250mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: COMA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
Anaesthesia. Vol. 47, Pg. 781, 1992.

 

Specification

Isoniazid (CAS NO.7640-37-1), its Synonyms are 4-(Hydrazinocarbonyl)pyridine ; 4-Pyridinecarbonylhydrazine ; 4-Pyridinecarboxylic acid, hydrazide ; 4-Pyridinecarboxylic hydrazide ; 4-Pyridylcarbonylhydrazide ; Antimicina ; Antituberkulosum ; Armazid ; Armazide ; Isonicotinic acid hydrazide ; Isonicotinic hydrazide ; Isonicotinohydrazide .